Activating diverse signaling pathways, such as the β-catenin and Act 1 adaptor protein (ACT 1) mediated pathways, is a crucial aspect of COPD pathogenesis triggered by IL-17. The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.